Table 4.
Association of baseline characteristics with MALE and POD in Rutherford category IV.
| Univariate analysis | Multivariate analysis | |
|---|---|---|
| Patient characteristics | ||
| Age | 1.0 (0.9, 1.0)* | – |
| >80 years | 0.6 (0.2, 1.6) | – |
| <70 years | 2.3 (1.1, 5.1)* | 2.1 (0.9, 4.7) |
| <60 years | 2.3 (0.7, 7.8) | – |
| Male gender | 0.7 (0.3, 1.5) | – |
| BMI < 18.5 kg/m3 | 2.6 (1.1, 6.6)* | 3.3 (1.3, 8.6)* |
| Non-ambulatory | 1.4 (0.6, 3.4) | – |
| Albumin < 3.0 g/dL | 1.4 (0.3, 6.0) | – |
| CRP > 3.0 mg/dL | 1.9 (0.6, 6.3) | – |
| Hypertension | 0.5 (0.2, 1.1) | – |
| Dyslipidemia | 0.9 (0.4, 1.9) | – |
| Diabetes mellitus | 0.5 (0.2, 1.1) | – |
| End stage of renal disease | 2.0 (0.9, 4.7) | – |
| Current smoking | 0.6 (0.3, 1.5) | – |
| COPD | 0.6 (0.1, 4.7) | – |
| CAD | 1.1 (0.5, 2.4) | – |
| CVD | 1.0 (0.4, 2.6) | – |
| Cilostazol | 1.0 (0.5, 2.2) | – |
| Statin | 0.5 (0.2, 1.5) | – |
| Lesion characteristics | ||
| BTK lesion length | 1.0 (1.0, 1.0) | – |
| CTO | 0.9 (0.4, 2.0) | – |
| BTK run-off vessels | 1.0 (0.6, 1.6) | – |
| BA disease | 0.9 (0.6, 1.5) | – |
| Procedure success | ||
| Success | 0.1 (0.0, 0.3)**** | 0.1 (0.0, 0.3)**** |
Data are hazard ratios and 95% confidence intervals.
MALE: major adverse limb events; POD: perioperative death; BMI: body mass index; CRP: C-reactive protein; COPD: chronic obstructive pulmonary disease; CAD: coronary artery disease; CVD: cerebral vascular disease; BTK: below-the-knee; CTO: chronic total occlusion; BA: below-the-ankle.
*
p < 0.05; ****p < 0.0005.